Versant bets $30M on next-gen gene delivery startup Vector

Versant Ventures has committed $30 million to improve gene delivery. By pumping the cash into Vector BioPharma, the VC is aiming to address the limitations of existing systems such as the cap on the size of the genetic cargo.